Chronic News and Research

RSS

COVID-19 'bites the apple': Abdominal obesity ignites cytokine storm

Abdominal obesity increases the risk of severe COVID-19 and mortality due to heightened inflammatory responses, according to a study on Japanese patients and a murine COVID-19 model. Blocking inflammatory cytokines and preventing obesity may improve survival rates.

24 May 2023

Researchers use AI models to advance drug delivery system for chronic eye diseases

Wilmer Eye Institute, Johns Hopkins Medicine researchers say they have used artificial intelligence models and machine-learning algorithms to successfully predict which components of amino acids that make up therapeutic proteins are most likely to safely deliver therapeutic drugs to animal eye cells.

24 May 2023

Long-term exposure to air pollution associated with higher risk of developing severe COVID-19

A long history of exposure to air pollution is associated with a higher risk of developing severe disease, admission to hospital or an intensive care unit (ICU) and death by COVID‑19 according to a study led by the Barcelona Institute for Global Health (ISGlobal), a research centre supported by the "la Caixa" Foundation.

24 May 2023

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

A study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher risk of developing cardiovascular disease, heart attack or atrial fibrillation (AFib), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

24 May 2023

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.

24 May 2023

Keto vs. low-fat diets: which is more sustainable in the long term?

Researchers investigated whether commercial weight loss diets meet nutrient requirements.

24 May 2023

As water levels drop, the risk of arsenic poisoning rises

When John Mestas’ ancestors moved to Colorado over 100 years ago to raise sheep in the San Luis Valley, they “hit paradise,” he said.

24 May 2023

New tests based on biomarkers may improve diagnosis and treatment of acute kidney injury

Hospital inpatients who develop an acute kidney injury (AKI) generally fare poorly after being discharged, and have few options for effective treatment.

24 May 2023

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Epstein-Barr virus (EBV) has a significant role in the development of multiple sclerosis (MS), with evidence linking EBV infection to increased MS risk and immune dysregulation. Understanding the mechanisms underlying this connection is crucial for advancing MS therapies and prevention strategies.

24 May 2023

Hypnotic drug class may not have increased the risk of exacerbations and death among COPD patients

Chronic obstructive pulmonary disease patients newly prescribed non-benzodiazepine benzodiazepine receptor agonists (NBZRAs) such as zolpidem (Ambien, Intermezzo and other brands), a class of hypnotic drugs prescribed for insomnia, did not have an increased risk of exacerbations requiring hospitalizations or of death than those prescribed other types of hypnotics, according to research published at the ATS 2023 International Conference.

24 May 2023

Oxygen restriction associated with longer lifespan in lab mice

For the first time, researchers have shown that reduced oxygen intake, or "oxygen restriction", is associated with longer lifespan in lab mice, highlighting its anti-aging potential.

24 May 2023

Processed danger: Industrial food additives and the health risks to children

Researchers explore the potential negative health effects on children due to the use of industrial additives in processing.

23 May 2023

Reseachers use CT scans to track the progression of emphysema over time

Researchers at National Jewish Health evaluating computerized tomography (CT) scans of emphysema progression in the COPDGene® study showed that, during a span of 10 years, participants with pre-existing emphysema who continued smoking had the largest decline in adjusted lung density (ALD).

23 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas - a wearable, pocket-sized, automated insulin delivery device - that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

New intervention program can help reduce opioid use for chronic pain

Researchers at the University of Warwick and The James Cook University Hospital, Middlesbrough have led a clinical trial, funded by the National Institute for Health and Care Research (NIHR), on a new treatment which can help people stop needing to use opioid painkillers to manage chronic pain.

23 May 2023

New research highlights the incredible resiliency among adult survivors of childhood physical abuse

New research published online in Children and Youth Services Review found that approximately two thirds (63%) of adult survivors of childhood physical abuse are in complete mental health, also known as psychologically flourishing.

23 May 2023

Innovative magnetic muscle therapy could reverse decline in functional mobility, loss of muscle strength in older adults

A decline in functional mobility, loss of muscle strength and an increase in body fats are often associated with aging.

23 May 2023

Global analysis paints a picture of growing low back pain cases

Analysis of over 30 years of data has shown the number of cases of low back pain is growing, with modeling suggesting by 2050, 843 million people will be affected by the condition largely due to population increases and aging of populations.

23 May 2023

$11.6 million NIDA grant supports the study of cannabis effects on HIV-infected brains

Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.

23 May 2023

Modified version of anti-nausea drug can enter into cells and provide long-lasting pain relief

Altering the chemical properties of an anti-nausea drug enables it to enter an interior compartment of the cell and provide long-lasting pain relief, according to a new study led by researchers at NYU College of Dentistry's Pain Research Center.

22 May 2023

Chronic News and Research

COVID-19 'bites the apple': Abdominal obesity ignites cytokine storm

Researchers use AI models to advance drug delivery system for chronic eye diseases

Long-term exposure to air pollution associated with higher risk of developing severe COVID-19

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

Keto vs. low-fat diets: which is more sustainable in the long term?

As water levels drop, the risk of arsenic poisoning rises

New tests based on biomarkers may improve diagnosis and treatment of acute kidney injury

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Hypnotic drug class may not have increased the risk of exacerbations and death among COPD patients

Oxygen restriction associated with longer lifespan in lab mice

Processed danger: Industrial food additives and the health risks to children

Reseachers use CT scans to track the progression of emphysema over time

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

New intervention program can help reduce opioid use for chronic pain

New research highlights the incredible resiliency among adult survivors of childhood physical abuse

Innovative magnetic muscle therapy could reverse decline in functional mobility, loss of muscle strength in older adults

Global analysis paints a picture of growing low back pain cases

$11.6 million NIDA grant supports the study of cannabis effects on HIV-infected brains

Modified version of anti-nausea drug can enter into cells and provide long-lasting pain relief

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News